JAMIL WATERS: Open Payments
NPI 1699275255 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,851 in 108 payments from 18 companies in 2025. Trend: 2023 $1,668 · 2024 $3,105 · 2025 $1,851
Food & beverage: $1,658Education: $193
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $360 |
| Arcutis Biotherapeutics, Inc. | 34 | $239 |
| Galderma Laboratories, L.P. | 5 | $205 |
| ABBVIE INC. | 15 | $167 |
| LEO Pharma Inc. | 8 | $145 |
| Regeneron Healthcare Solutions, Inc. | 7 | $141 |
| Janssen Biotech, Inc. | 2 | $126 |
| SANOFI-AVENTIS U.S. LLC | 1 | $87 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $64 |
| Lilly USA, LLC | 2 | $50 |
Products named: DUPIXENT, Zoryve, NEMLUVIO, SKYRIZI, ADBRY, TREMFYA, TALTZ, Sotyktu.
Industry payments across TX — which companies pay providers there.
